BBIO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$67.89

Piyasa Değeri

$14.90B

P/E (TTM)

-20.2

EPS (TTM)

$-3.78

Gelir (TTM)

$502M

Temettü Verimi

—

ROE

41.2%

D/E Borç/Özsermaye

—

52 Haftlık Aralık

$32 – $85

BBIO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $502M

2019-12-31 → 2025-12-31

Hisse Başına Kâr $-3.78

2020-12-31 → 2025-12-31

Serbest Nakit Akışı $-447M

2019-12-31 → 2025-12-31

Marjlar -146.0%

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

P/E (TTM)

-20.2

21.9

P/S (TTM) (F/S (TTM))

29.7

12.8

P/B (F/D)

-7.1

9.8

Price / FCF (Fiyat / Serbest Nakit Akışı)

-33.3

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

Operating Margin (Faaliyet Kâr Marjı)

-104.2%

—

Net Profit Margin (Net Kâr Marjı)

-146.0%

-28.3%

ROA

-79.0%

-16.8%

ROE

41.2%

-44.0%

ROIC

25.1%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

Current Ratio (Cari Oran)

2.8

4.4

Quick Ratio (Cari Oran)

2.5

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

126.3%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

86.3%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

127.4%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$-3.78

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

BBIO

Akran Ortalaması

BBIO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 30 analist

Güçlü Al 9 30,0%
Al 20 66,7%
Tut 1 3,3%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

22 analist · 2026-05-17

Medyan $100.00

← Tüm hedeflerin altında $67.89

Düşük $76.00

Yüksek $157.00

Medyan hedef $100.00 +47,3%

Ortalama hedef $102.79 +51,4%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

-0.09%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$-0.84	$-0.69	-0.15%
31 Aralık 2025	$-1.00	$-0.76	-0.24%
30 Eylül 2025	$-0.95	$-0.91	-0.04%
30 Haziran 2025	$-0.95	$-0.86	-0.09%
31 Mart 2025	$-0.88	$-0.94	0.06%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
BBIO	$14.90B	-20.2	126.3%	-146.0%	41.2%	—
INSM	$37.29B	-27.1	66.7%	-210.5%	-128.4%	—
INCY	$19.60B	15.4	21.2%	25.0%	27.6%	—
MRNA	$11.62B	-4.1	-39.9%	-145.2%	-31.3%	—
NBIX	$14.20B	30.4	21.4%	16.7%	16.1%	—
SMMT	$13.56B	-12.1	—	—	-235.1%	—
EXEL	$11.44B	15.7	7.0%	33.7%	37.3%	—
IONS	$12.92B	-33.2	—	—	-68.1%	—
MDGL	$13.30B	-45.3	432.1%	-30.1%	-44.4%	—
ARWR	$4.68B	-3449.0	23258.2%	-0.20%	-0.50%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 17

BBIO için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$502M	$222M	$9M	$78M	$70M	$8M	$41M
Cost of Revenue	$21M	$4M	$2M	$3M	$3M	·	·
R&D Expense	$452M	$506M	$456M	$399M	$451M	$337M	$210M
SG&A Expense	$531M	$289M	$151M	$143M	$192M	$146M	$94M
Operating Expenses	$1.03B	$815M	$617M	$590M	$646M	$483M	$307M
Operating Income	$-523M	$-593M	$-607M	$-512M	$-577M	$-474M	$-266M
Interest Expense	·	·	$81M	$80M	$47M	$37M	$9M
Interest Income	$20M	$17M	$18M	$8M	$1M	$4M	$9M
Other Non-op	$43M	$12M	$17M	$-8M	$36M	$2M	$-2M
Pretax Income	$-733M	$-542M	$-653M	$-485M	·	$505M	$289M
Income Tax	$435.0K	$1M	$0	$0	·	·	·
Net Income	$-733M	$-543M	$-653M	$-485M	$-586M	$-505M	$-289M
EPS (Basic)	$-3.78	$-2.88	$-3.95	$-3.26	$-3.90	$-3.80	·
EPS (Diluted)	$-3.78	$-2.88	$-3.95	$-3.26	$-3.90	$-3.80	·
Shares (Basic)	191,527,482	186,075,873	162,791,511	147,473,076	144,356,619	117,995,457	·
Shares (Diluted)	191,527,482	186,075,873	162,791,511	147,473,076	144,356,619	117,995,457	·
EBITDA	$-518M	$-587M	$-601M	$-505M	$-571M	$-474M	$-266M

Bilanço 26

BBIO için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$570M	$681M	$376M	$377M	$394M	$356M	$364M
Short-term Investments	·	$0	$0	$52M	$394M	$251M	$182M
Receivables	$139M	$5M	$2M	·	·	·	·
Inventory	$27M	$0	·	·	·	·	·
Prepaid Expense	$44M	$35M	$24M	$22M	$32M	$36M	$20M
Current Assets	$798M	$721M	$478M	$549M	$889M	$643M	$569M
PP&E (Net)	$5M	$7M	$12M	$15M	$30M	$20M	$6M
Intangibles	$28M	$24M	$26M	$29M	$45M	$0	·
Other Non-current Assets	$17M	$18M	$23M	$20M	$33M	$24M	$26M
Total Assets	$936M	$919M	$546M	$623M	$1.01B	$704M	$632M
Accounts Payable	$36M	$10M	$11M	$12M	$12M	$9M	$9M
Accrued Liabilities	·	·	·	·	·	·	$3M
Current Liabilities	$288M	$154M	$144M	$121M	$135M	$96M	$60M
Capital Leases	$4M	$5M	$9M	$12M	$17M	$15M	·
Other Non-current Liabilities	$244.0K	$286.0K	$6M	$27M	$22M	$10M	$4M
Total Liabilities	$3.01B	$2.38B	$1.89B	$1.87B	$1.88B	$596M	$156M
Long-term Debt	$2.01B	·	·	·	·	$94M	$95M
Total Debt	·	$437M	$446M	$431M	$431M	$94M	$92M
Common Stock	$202.0K	$196.0K	$181.0K	$157.0K	$154.0K	$125.0K	$124.0K
Paid-in Capital	$2.06B	$1.90B	·	·	·	·	·
Retained Earnings	$-3.82B	$-3.10B	$-2.56B	$-1.92B	$-1.44B	$-889M	$-440M
Treasury Stock	$323M	$275M	$275M	$275M	$275M	$75M	·
AOCI	$12.0K	$8.0K	$31.0K	$-328.0K	$-132.0K	$192.0K	$254.0K
Stockholders' Equity	$-2.09B	$-1.47B	$-1.35B	$-1.25B	$-870M	$58M	$408M
Liabilities + Equity	$936M	$919M	$546M	$623M	$1.01B	$704M	$632M
Shares Outstanding	194,771,957	190,044,473	175,082,951	150,625,572	147,343,323	122,849,389	123,658,287

Nakit Akışı 18

BBIO için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$5M	$6M	$6M	$7M	$6M	$1M	$859.0K
Stock-based Comp	$133M	$96M	$109M	$92M	$100M	$58M	$21M
Deferred Tax	$0	$0	$0	·	·	·	·
Amort. of Intangibles	$3M	$2M	$2M	$2M	$3M	·	·
Restructuring	·	$16M	$8M	$44M	$0	$0	·
Other Non-cash	$149M	$-79M	$10M	$-33M	$-17M	·	·
Operating Cash Flow	$-446M	$-521M	$-528M	$-419M	$-498M	$-400M	$-254M
CapEx	$1M	$933.0K	$1M	$5M	$13M	$8M	$3M
Investing Cash Flow	$-24M	$61M	$54M	$453M	$-201M	$-53M	$-217M
Net Debt Issued	·	$-473M	$0	$-20M	$-124M	·	·
Stock Issued	$0	$315M	$450M	$5M	$0	$0	·
Stock Repurchased	$48M	$0	$0	$0	$200M	$75M	·
Net Stock Activity	$-48M	$315M	$144M	$5M	$-200M	$-75M	·
Dividends Paid	·	·	·	·	·	·	$997.0K
Financing Cash Flow	$359M	$748M	$452M	$-13M	$736M	$447M	$399M
Net Change in Cash	$-111M	$289M	$-22M	$21M	$38M	$-6M	$-72M
Taxes Paid	$1M	$0	$0	·	·	·	·
Free Cash Flow	$-447M	$-522M	$-529M	$-424M	$-511M	$-407M	$-256M

Kârlılık 7

BBIO için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-104.2%	-267.2%	-6528.7%	-659.6%	-827.1%	-5752.0%	-656.4%
Net Margin	-146.0%	-244.9%	-7021.9%	-624.2%	-841.2%	-6127.9%	-711.5%
Pretax Margin	-145.9%	-244.3%	·	·	·	6127.9%	711.5%
EBITDA Margin	-103.2%	-264.5%	-6458.9%	-650.9%	-818.7%	-5752.0%	-656.4%
ROA	-79.0%	-74.1%	-111.7%	-59.2%	-68.3%	-75.7%	-52.6%
ROE	41.2%	38.5%	50.1%	45.6%	144.4%	-216.8%	-101.0%
ROIC	25.1%	57.7%	·	·	·	·	·

Likidite ve Solventlik 5

BBIO için Yıllık Likidite ve Solventlik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Current Ratio	2.8	4.7	3.3	4.5	6.6	6.7	9.4
Quick Ratio	2.5	4.4	2.6	3.5	5.8	6.3	9.0
Debt / Equity	·	-0.3	-0.3	-0.3	-0.5	1.6	0.2
LT Debt / Equity	·	-0.3	-0.3	-0.3	-0.5	1.6	0.2
Interest Coverage	·	·	-7.5	-6.4	-12.3	-12.9	-30.4

Verimlilik 3

BBIO için Yıllık Verimlilik verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.5	0.3	0.0	0.1	0.1	0.0	0.1
Inventory Turnover	1.6	·	·	·	·	·	·
Receivables Turnover	7.0	68.6	·	·	·	·	·

Hisse Başına 5

BBIO için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$-10.71	$-7.72	$-7.73	$-8.33	$-5.91	$0.47	$3.30
Revenue / Share	$2.62	$1.19	$0.06	$0.53	·	·	·
Cash Flow / Share	$-2.33	$-2.80	$-3.24	$-2.84	·	·	·
Cash / Share	$2.93	$3.58	$2.15	$2.50	$2.67	$2.90	$2.94
EPS (TTM)	$-3.78	$-2.88	$-3.95	$-3.26	$-3.90	$-3.80	·

Büyüme Oranları 3

BBIO için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	126.3%	2285.3%	-88.0%	11.4%	745.1%	·	·
Revenue CAGR 3Y	86.3%	47.1%	4.1%	·	·	·	·
Revenue CAGR 5Y	127.4%	·	·	·	·	·	·

Değerleme (TTM) 17

BBIO için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$502M	$222M	$9M	$78M	$70M	$8M	$41M
Net Income TTM	$-733M	$-543M	$-653M	$-485M	$-586M	$-505M	$-289M
Market Cap	$14.90B	$5.21B	$7.07B	$1.15B	$2.46B	$8.74B	$4.33B
Enterprise Value	·	$4.97B	$7.14B	$1.15B	$2.10B	$8.22B	$3.88B
P/E	-20.2	-9.5	-10.2	-2.3	-4.3	-18.7	·
P/S	29.7	23.5	759.8	14.8	35.3	1059.0	106.9
P/B	-7.1	-3.6	-5.2	-0.9	-2.8	150.9	10.6
P / Tangible Book	·	·	·	·	·	150.9	·
P / Cash Flow	-33.4	-10.0	-13.4	-2.7	-4.9	-21.9	-17.1
P / FCF	-33.3	-10.0	-13.4	-2.7	-4.8	-21.5	-16.9
EV / EBITDA	·	-8.5	-11.9	-2.3	-3.7	-17.3	-14.6
EV / FCF	·	-9.5	-13.5	-2.7	-4.1	-20.2	-15.1
EV / Revenue	·	22.4	767.3	14.8	30.1	996.8	95.7
Dividend Yield	·	·	·	·	·	·	0.02%
Earnings Yield	-4.9%	-10.5%	-9.8%	-42.8%	-23.4%	-5.3%	·
Payout Ratio	·	·	·	·	·	·	-0.35%
Annual Payout	·	·	·	·	·	·	$997.0K

Gelir Tablosu 17

BBIO için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$195M	$154M	$121M	$111M	$117M	$6M	$3M	$2M	$211M	$2M	$4M	$2M	$2M	$2M	$338.0K	$74M
Cost of Revenue	$10M	$8M	$7M	$4M	$3M	$2M	$598.0K	$598.0K	$598.0K	$598.0K	$598.0K	$599.0K	$651.0K	$647.0K	$739.0K	$700.0K
R&D Expense	$127M	$116M	$113M	$111M	$111M	$130M	$120M	$115M	$141M	$130M	$125M	$107M	$93M	$91M	$93M	$108M
SG&A Expense	$164M	$158M	$138M	$129M	$106M	$95M	$69M	$60M	$66M	$48M	$36M	$36M	$31M	$32M	$31M	$36M
Operating Expenses	$300M	$294M	$266M	$245M	$221M	$232M	$194M	$178M	$211M	$179M	$162M	$148M	$128M	$131M	$129M	$154M
Operating Income	$-106M	$-140M	$-145M	$-134M	$-104M	$-226M	$-192M	$-176M	$343.0K	$-177M	$-158M	$-146M	$-126M	$-129M	$-129M	$-80M
Interest Expense	·	·	·	·	·	·	·	$23M	$23M	·	$20M	$21M	$20M	·	$20M	$20M
Interest Income	$6M	$4M	$6M	$4M	$5M	$5M	$3M	$5M	$4M	$6M	$4M	$5M	$4M	$4M	$2M	$766.0K
Other Non-op	$4M	$12M	$16M	$7M	$8M	$2M	$2M	$-632.0K	$9M	$22M	$-5M	$1M	$-601.0K	$5M	$6M	$-11M
Pretax Income	·	$-195M	$-186M	$-182M	·	$-266M	$-164M	$-76M	·	·	·	·	·	·	·	·
Income Tax	·	$-120.0K	$-2M	$2M	$0	$1M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$-167M	$-195M	$-185M	$-184M	$-170M	$-267M	$-164M	$-76M	$-36M	$-170M	$-179M	$-161M	$-143M	$-141M	$-140M	$-3M
EPS (Basic)	$-0.84	$-1.00	$-0.95	$-0.95	$-0.88	$-1.43	$-0.86	$-0.39	$-0.20	$-0.97	$-1.08	$-0.98	$-0.92	$-0.91	$-0.93	$-0.07
EPS (Diluted)	$-0.84	$-1.00	$-0.95	$-0.95	$-0.88	$-1.43	$-0.86	$-0.39	$-0.20	$-0.97	$-1.08	$-0.98	$-0.92	$-0.91	$-0.93	$-0.07
Shares (Basic)	194,789,897	-380,989,138	191,854,152	190,517,215	190,145,253	-368,726,489	188,510,372	187,586,680	178,705,310	-313,698,191	163,308,632	160,535,435	152,645,635	-293,031,694	147,937,817	146,684,804
Shares (Diluted)	194,789,897	-380,989,138	191,854,152	190,517,215	190,145,253	-368,726,489	188,510,372	187,586,680	178,705,310	-313,698,191	163,308,632	160,535,435	152,645,635	-293,031,694	147,937,817	146,684,804
EBITDA	$-105M	·	$-145M	$-134M	$-103M	·	$-192M	$-176M	$2M	·	$-158M	$-146M	$-125M	·	$-129M	$-80M

Bilanço 25

BBIO için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$880M	$570M	$643M	$749M	$541M	$681M	$266M	$408M	$475M	$376M	$505M	$302M	$407M	$377M	$483M	$470M
Short-term Investments	·	·	·	$8M	·	·	·	$40M	$44M	·	$0	$31M	$34M	·	$75M	$218M
Receivables	$205M	$139M	$117M	$77M	$115M	$5M	·	·	·	·	·	·	·	·	·	·
Inventory	$33M	$27M	$25M	$18M	$4M	$0	·	·	·	·	·	·	·	·	·	·
Prepaid Expense	$63M	$44M	$52M	$60M	$35M	$35M	$38M	$28M	$28M	·	$23M	$21M	$25M	·	$26M	$33M
Current Assets	$1.24B	$798M	$839M	$912M	$695M	$721M	$445M	$616M	$783M	·	$588M	$433M	$553M	·	$642M	$771M
PP&E (Net)	$5M	$5M	$6M	$6M	$7M	$7M	$9M	$10M	$11M	·	$12M	$13M	$14M	·	$16M	$17M
Intangibles	$27M	$28M	$29M	$30M	$28M	$24M	$25M	$25M	$26M	·	$27M	$28M	$28M	·	$29M	$30M
Other Non-current Assets	$19M	$17M	$26M	$18M	$17M	$18M	$20M	$19M	$21M	·	$19M	$20M	$21M	·	$30M	$31M
Total Assets	$1.37B	$936M	$998M	$1.08B	$882M	$919M	$665M	$794M	$849M	·	$655M	$504M	$626M	·	$729M	$862M
Accounts Payable	$29M	$36M	$19M	$26M	$28M	$10M	$13M	$18M	$5M	·	$4M	$4M	$4M	·	$10M	$9M
Current Liabilities	$816M	$288M	$217M	$176M	$152M	$154M	$139M	$134M	$141M	·	$106M	$110M	$97M	·	$119M	$141M
Capital Leases	$14M	$4M	$3M	$4M	$5M	$5M	$6M	$7M	$8M	·	$10M	$11M	$12M	·	$13M	$14M
Other Non-current Liabilities	$229.0K	$244.0K	$679.0K	$545.0K	$352.0K	$286.0K	$377.0K	$485.0K	$595.0K	·	$12M	$13M	$18M	·	$28M	$29M
Total Liabilities	$3.64B	$3.01B	$2.92B	$2.86B	$2.52B	$2.38B	$1.88B	$1.88B	$1.89B	·	$1.85B	$1.85B	$1.84B	·	$1.86B	$1.88B
Long-term Debt	$2.65B	$2.01B	$2.01B	·	·	·	·	·	·	·	·	·	·	·	·	·
Total Debt	·	·	·	$0	$0	·	$436M	$435M	$435M	·	$442M	$440M	$436M	·	·	·
Common Stock	$204.0K	$202.0K	$200.0K	$198.0K	$197.0K	$196.0K	$195.0K	$194.0K	$193.0K	·	$180.0K	$168.0K	$167.0K	·	$156.0K	$154.0K
Paid-in Capital	$2.11B	$2.06B	$2.02B	·	·	$1.90B	·	·	·	·	·	·	·	·	·	·
Retained Earnings	$-3.99B	$-3.82B	$-3.63B	$-3.45B	$-3.26B	$-3.10B	$-2.83B	$-2.67B	$-2.60B	·	$-2.39B	$-2.22B	$-2.06B	·	$-1.78B	$-1.64B
Treasury Stock	$406M	$323M	$323M	$323M	$323M	$275M	$275M	$275M	$275M	·	$275M	$275M	$275M	·	$275M	$275M
AOCI	$-8.0K	$12.0K	$2.0K	$1.0K	$0	$8.0K	$5.0K	$-4.0K	$2.0K	·	$34.0K	$63.0K	$-12.0K	·	$-348.0K	$-427.0K
Stockholders' Equity	$-2.28B	$-2.09B	$-1.93B	$-1.79B	$-1.65B	$-1.47B	$-1.23B	$-1.09B	$-1.05B	·	$-1.21B	$-1.36B	$-1.23B	·	$-1.14B	$-1.03B
Liabilities + Equity	$1.37B	$936M	$998M	$1.08B	$882M	$919M	$665M	$794M	$849M	·	$655M	$504M	$626M	·	$729M	$862M
Shares Outstanding	195,707,702	194,771,957	192,633,286	191,162,659	189,826,023	190,044,473	188,986,547	188,032,738	187,122,744	175,082,951	174,131,954	161,419,931	160,435,238	·	149,367,087	148,243,197

Nakit Akışı 16

BBIO için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	$33M	$35M	$35M	$37M	$26M	$30M	$27M	$21M	$17M	$37M	$23M	$27M	$22M	$22M	$17M	$28M
Amort. of Intangibles	$700.0K	$700.0K	$700.0K	$700.0K	$600.0K	$600.0K	$600.0K	$600.0K	$600.0K	$600.0K	$600.0K	$600.0K	$600.0K	$300.0K	$600.0K	$600.0K
Restructuring	·	·	·	·	·	·	$5M	$3M	$3M	·	$272.0K	$4M	$3M	$8M	$5M	$8M
Other Non-cash	$-65M	·	·	·	$-57M	·	·	·	$-202M	·	·	·	$-25M	·	·	·
Operating Cash Flow	$-197M	$-56M	$-110M	$-81M	$-199M	$-195M	$-181M	$75M	$-220M	$-125M	$-145M	$-113M	$-144M	$-93M	$-135M	$-30M
CapEx	$69.0K	$33.0K	$470.0K	$594.0K	$0	$47.0K	$137.0K	$54.0K	$695.0K	$435.0K	$431.0K	$428.0K	$12.0K	$801.0K	$759.0K	$2M
Investing Cash Flow	$-43M	$-14M	$4M	$-13M	$-2M	$-3M	$38M	$3M	$23M	$-66.0K	$38M	$4M	$12M	$18M	$147M	$150M
Debt Issued	·	·	·	·	·	·	$0	$0	$450M	·	$0	$0	$0	·	·	·
Net Debt Issued	·	·	·	·	$-459M	·	·	·	$-23M	·	·	·	·	·	·	·
Stock Issued	·	$0	$0	$0	$0	$0	$-18.0K	$-495.0K	$315M	$-454.0K	$306M	$1M	$143M	$5M	$0	$0
Stock Repurchased	$82M	$0	$0	$0	$48M	$0	$0	$0	$0	·	·	·	·	·	·	·
Net Stock Activity	$-82M	·	·	·	$-48M	·	·	·	$315M	·	·	·	$143M	·	·	·
Financing Cash Flow	$550M	$-2M	$-894.0K	$302M	$60M	$474M	$707.0K	$-6M	$280M	$-5M	$307M	$-1M	$150M	$6M	$1M	$-21M
Net Change in Cash	$310M	$-73M	$-106M	$208M	$-141M	$275M	$-142M	$72M	$83M	$-129M	$199M	$-110M	$18M	$-69M	$13M	$98M
Free Cash Flow	$-197M	·	·	·	$-199M	·	·	·	$-220M	·	·	·	$-144M	·	·	·

Kârlılık 7

BBIO için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-54.5%	·	-120.3%	-121.4%	-89.5%	·	-7018.7%	-8096.8%	0.16%	·	-3854.6%	-8903.1%	-6909.3%	·	-38200.0%	-108.7%
Net Margin	-85.6%	·	-153.2%	-166.2%	-145.4%	·	-6012.2%	-3484.5%	-17.1%	·	-4387.4%	-9793.0%	-7816.6%	·	-41477.2%	-3.5%
Pretax Margin	·	·	-154.5%	-164.3%	·	·	·	·	·	·	·	·	·	·	·	·
EBITDA Margin	-53.9%	·	-120.3%	-121.4%	-88.4%	·	-7018.7%	-8096.8%	0.92%	·	-3854.6%	-8903.1%	-6819.8%	·	-38200.0%	-108.7%
ROA	-14.8%	·	-22.2%	-19.6%	-19.6%	·	-24.9%	-11.6%	-4.9%	·	-25.9%	-23.5%	-19.8%	·	-18.6%	-0.26%
ROE	8.5%	·	11.7%	12.8%	12.6%	·	13.5%	6.2%	3.2%	·	15.3%	13.5%	12.6%	·	14.9%	0.34%
ROIC	·	·	7.4%	7.6%	·	·	·	·	·	·	·	·	·	·	·	·

Likidite ve Solventlik 5

BBIO için Çeyreklik Likidite ve Solventlik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	1.5	·	3.9	5.2	4.6	·	3.2	4.6	5.5	·	5.5	3.9	5.7	·	5.4	5.5
Quick Ratio	1.3	·	3.5	4.7	4.3	·	1.9	3.3	3.7	·	4.8	3.0	4.6	·	4.7	4.9
Debt / Equity	·	·	·	0.0	0.0	·	-0.4	-0.4	-0.4	·	-0.4	-0.3	-0.4	·	·	·
LT Debt / Equity	·	·	·	0.0	0.0	·	-0.4	-0.4	-0.4	·	-0.4	-0.3	-0.4	·	·	·
Interest Coverage	·	·	·	·	·	·	·	-7.7	0.0	·	-7.8	-7.1	-6.3	·	-6.5	-4.0

Verimlilik 3

BBIO için Çeyreklik Verimlilik verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.2	·	0.1	0.1	0.1	·	0.0	0.0	0.3	·	0.0	0.0	0.0	·	0.0	0.1
Inventory Turnover	0.5	·	0.5	0.4	1.3	·	·	·	·	·	·	·	·	·	·	·
Receivables Turnover	1.2	·	2.1	2.8	2.0	·	·	·	·	·	·	·	·	·	·	·

Hisse Başına 5

BBIO için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$-11.64	·	$-10.04	$-9.35	$-8.68	·	$-6.51	$-5.81	$-5.61	·	$-6.93	$-8.44	$-7.64	·	$-7.62	$-6.92
Revenue / Share	$1.00	·	$0.63	$0.58	$0.61	·	$0.01	$0.01	$1.18	·	$0.03	$0.01	$0.01	·	$0.00	$0.50
Cash Flow / Share	$-1.01	·	·	·	$-1.05	·	·	·	$-1.23	·	·	·	$-0.95	·	·	·
Cash / Share	$4.50	·	$3.34	$3.92	$2.85	·	$1.41	$2.17	$2.54	·	$2.90	$1.87	$2.54	·	$3.24	$3.17
EPS (TTM)	$-3.62	·	$-3.64	$-3.08	$-2.33	·	$-2.53	$-2.65	$-3.18	·	$-3.91	$-2.90	$-3.27	·	$-3.41	$-3.14

Değerleme (TTM) 13

BBIO için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$542M	·	$351M	$232M	$333M	·	$220M	$219M	$219M	·	$8M	$78M	$78M	·	$78M	$132M
Net Income TTM	$-705M	·	$-703M	$-593M	$-446M	·	$-455M	$-452M	$-519M	·	$-623M	$-446M	$-487M	·	$-505M	$-467M
Market Cap	$14.53B	·	$10.01B	$8.25B	$6.56B	·	$4.81B	$4.76B	$5.79B	·	$4.59B	$2.78B	$2.66B	·	$1.48B	$1.35B
Enterprise Value	·	·	·	$7.50B	$6.02B	·	$4.98B	$4.75B	$5.70B	·	$4.53B	$2.88B	$2.65B	·	·	·
P/E	-20.5	·	-14.3	-14.0	-14.8	·	-10.1	-9.6	-9.7	·	-6.7	-5.9	-5.1	·	-2.9	-2.9
P/S	26.8	·	28.5	35.6	19.7	·	21.9	21.7	26.5	·	581.5	35.8	34.3	·	19.0	10.2
P/B	-6.4	·	-5.2	-4.6	-4.0	·	-3.9	-4.4	-5.5	·	-3.8	-2.0	-2.2	·	-1.3	-1.3
P / Cash Flow	-73.7	·	·	·	-32.9	·	·	·	-26.4	·	·	·	-18.4	·	·	·
P / FCF	-73.6	·	·	·	-32.9	·	·	·	-26.3	·	·	·	-18.4	·	·	·
EV / EBITDA	·	·	·	-55.8	-58.4	·	-26.0	-27.1	2940.1	·	-28.7	-19.7	-21.3	·	·	·
EV / FCF	·	·	·	·	-30.2	·	·	·	-25.9	·	·	·	-18.4	·	·	·
EV / Revenue	·	·	·	32.3	18.1	·	22.6	21.7	26.1	·	573.5	37.2	34.2	·	·	·
Earnings Yield	-4.9%	·	-7.0%	-7.1%	-6.7%	·	-9.9%	-10.5%	-10.3%	·	-14.8%	-16.9%	-19.7%	·	-34.3%	-34.6%

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$502M	$222M	$9M	$78M	$70M
Faaliyet Kâr Marjı %	-104.2%	-267.2%	-6528.7%	-659.6%	-827.1%
Net Gelir	$-733M	$-543M	$-653M	$-485M	$-586M
Seyreltilmiş Hisse Başı Kâr	$-3.78	$-2.88	$-3.95	$-3.26	$-3.90

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Borç / Öz Sermaye	—	-0.3	-0.3	-0.3	-0.5
Cari Oran	2.8	4.7	3.3	4.5	6.6
Cari Oran	2.5	4.4	2.6	3.5	5.8

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-447M	$-522M	$-529M	$-424M	$-511M

Son Haberler Bu şirketten bahseden son manşetler

Anlamlı Bir Destekçisini Kaybeden Düşüşteki Biyoteknoloji Şirketi - Umursamalı mısınız? Nasdaq · 23 saat, 7 dakika önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

BBIO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

BBIO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

BBIO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Son Haberler Bu şirketten bahseden son manşetler

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar